Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Operating Income (2023 - 2025)

Historic Operating Income for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$56.4 million.

  • Nuvation Bio's Operating Income fell 1732.4% to -$56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$233.0 million, marking a year-over-year increase of 5836.24%. This contributed to the annual value of -$592.6 million for FY2024, which is 49368.38% down from last year.
  • As of Q3 2025, Nuvation Bio's Operating Income stood at -$56.4 million, which was down 1732.4% from -$63.6 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Operating Income registered a high of -$20.2 million during Q1 2024, and its lowest value of -$470.4 million during Q2 2024.
  • In the last 3 years, Nuvation Bio's Operating Income had a median value of -$48.1 million in 2024 and averaged -$79.2 million.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 170010.33% in 2024, then soared by 8648.15% in 2025.
  • Over the past 3 years, Nuvation Bio's Operating Income (Quarter) stood at -$20.8 million in 2023, then tumbled by 158.95% to -$53.9 million in 2024, then fell by 4.62% to -$56.4 million in 2025.
  • Its Operating Income stands at -$56.4 million for Q3 2025, versus -$63.6 million for Q2 2025 and -$59.0 million for Q1 2025.